Dáil Éireann Debate, Tuesday - 21 November 2023
574. Deputy Colm Burke asked the Minister for Health if any health technology assessments regarding individual medicines have been subject to external review or audit, or if any international comparisons have been undertaken; and if he will make a statement on the matter. [51078/23]
View answerThe NCPE is an active participant in many ongoing international HTA collaborations including the Beneluxa Initiative, EUnetHTA21 and the International Horizon Scanning Initiative. The NCPE are a leading organisation in the BENELUXA initiative and have produced two joint HTA reports as part of this collaboration: Onasemnogene abeparvovec (Zolgensma) and Atidarsagene (Libmeldy).
The NCPE participated as authors/co-authors on four joint clinical assessments and collaborative assessments as part of Joint Action 3 of EUNETHTA. This collaborative work includes peer review with other international HTA agencies. The NCPE is also leading on the development of methodological guidelines on behalf of the EU Member State Coordination Group on HTA, for joint assessments on the comparative effectiveness of drugs.
